Totalkredit A/S
To Nasdaq Copenhagen
10 March 2021
Convening of annual general meeting of Totalkredit A/S
Totalkredit A/S will hold its annual general meeting on Wednesday 24 March 2021 at 10:00 at the Company's offices at Kalvebod Brygge 1-3, DK-1560 Copenhagen V.
-o0o-
Agenda:
- The Directors' report on the Company's activities in the past year.
- Presentation of the Annual Report 2020 for approval and resolution on the discharge of the Board of Directors and Executive Board.
- Proposal for the appropriation of profit according to the approved Annual Report.
- Election of members of the Board of Directors.
- Appointment of auditors.
- Remuneration matters, including the remuneration policy for approval.
- Any other business.
The agenda of the Company's general meeting, its updated remuneration policy as well as its Annual Report will be available for inspection by the shareholders at the Company's address prior to the general meeting.
Item 4 on the agenda proposes re-election of Michael Rasmussen, David Hellemann and Anders Jensen for the Board of Directors.
As item 5 on the agenda the Board of Directors proposes appointment of EY Godkendt Revisionspartnerselskab as auditors of the Company as recommended by the Board Audit Committee.
Admittance to the general meeting is subject to collection of an admission card at least three days prior to the general meeting.
It should be noted that Nykredit Realkredit A/S owns all the shares of the Company.
Copenhagen, 10 March 2021
Totalkredit A/S
Board of Directors
Contact:
Questions may be addressed to Press Relations, tel +45 20 37 28 69.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
Zealand Pharma17.10.2025 17:05:17 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom